Form D · Other Health Care
R2T2 Laboratories Inc.
Sag Harbor, NY · CIK 0001559625
Offering snapshot reported Feb 3, 2015 · SEC filing
- Reported sold
- $80.5K Offering amount: $80.5K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $22.2K Reported outside-investor minimum
- First sale
- Oct 21, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2015 | Initial | $80,500 | No comparison | 3 | SEC filing |
| Oct 17, 2012 | Initial | $625,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-233352
Source: Form D, filed Feb 3, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Parikhal | Executive |
| Taran Swan | Director, Executive |
| Riley J. Williams | Director, Executive |
| Tanya Williams | Director, Executive |
| Riley J Williams Iii | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
18 Cuffee Drive
Sag Harbor, NY, 11963
Sag Harbor, NY, 11963